NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy Company dedicated to the commercialization of cell therapy products for a variety of indications,...
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy company dedicated to the commercialization of stem cell products for a variety of indications, today...
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS) (Pluristem) announced today a licensing agreement and stock swap with Stem Cell Innovations, Inc. (OTCBB:SCLL) (Stem...
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy Company dedicated to the commercialization of stem cell products for a variety of indications, today...
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy company
dedicated to the commercialization of stem cell products, today
announced that it has...
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy company
dedicated to the commercialization of stem cell products, today
announced that it has...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of Pluristem Life Sciences
(OTCBB:PLRS), maintaining a speculative buy rating and a $.06 price
target....
#24: PLRS News Pluristem to Present at Annual Meeting of American Society of Hematology: Breakthrough Method Improves Engraftment of Umbilical Cord Blood in Treating Severe Blood Disorders
NEW YORK--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS) today announced that it has
been chosen to present at the annual meeting of the American Society of ...
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS), a cell therapy company
dedicated to the commercialization of stem cell products, today
announced that the...
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS), a cell therapy company
dedicated to the commercialization of stem cell products, today
announced that it...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of Pluristem Life Sciences
(OTCBB:PLRS) raising its rating to Speculative Buy with a $.06 price ...
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS) announces they have completed
the conversion of 98% of the $3,000,000 in convertible debentures that
were...
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB:PLRS) today announced that it has
completed the conversion to common stock of 98% of the $3,000,000 in
convertible...
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS) announces they have completed
upgrading and restructuring their manufacturing facilities to enable the ...